Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periprocedural Cangrelor in STEMI Patients
NCT03043274Phase 4Terminated
- Start
- Jan 2017
- Primary completion
- May 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in ST elevation myocardial infarction (STEMI). Started Jan 2017; status: terminated.
02
Drugs
cangrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03043274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043274.